Overview

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and efficacy of early corticosteroid withdrawal and simultaneous calcineurin inhibitor withdrawal in recipients of primary renal allografts maintained long-term on MMF and sirolimus.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Calcineurin Inhibitors
Everolimus
Mycophenolate mofetil
Mycophenolic Acid
Sirolimus